Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells

The difficulty of glioblastoma treatment makes it a good candidate for novel therapies, such as oncolytic viruses. Vesicular stomatitis virus expressing Lassa virus glycoprotein (Lassa-VSV) showed significant promise in animal models using established glioblastoma cell lines. These experiments were...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Teddy E., Puckett, Shelby, Zhang, Kailong, Herpai, Denise M., Ornelles, David A., Davis, John N., van den Pol, Anthony N., Debinski, Waldemar, Lyles, Douglas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424128/
https://www.ncbi.nlm.nih.gov/pubmed/34514102
http://dx.doi.org/10.1016/j.omto.2021.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424128/
https://www.ncbi.nlm.nih.gov/pubmed/34514102
http://dx.doi.org/10.1016/j.omto.2021.06.003

Ejemplares similares